Intrinsic value of Corcept Therapeutics Incorporated (CORT)
Live fair value data for Corcept Therapeutics Incorporated (CORT) is currently unavailable. Please check again shortly.
Current Price: $202.00
Valuation: Undervalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Corcept Therapeutics Incorporated (CORT) undervalued or overvalued?
Based on the current model output, Corcept Therapeutics Incorporated appears to be undervalued with a upside of 5.00%.
Fair value vs market price — Corcept Therapeutics Incorporated (CORT)
Unlock premium access to view the live fair value comparison against current market price for CORT.
Frequently Asked Questions - CORT
How is CORT intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for CORT.
Is CORT undervalued or overvalued right now?
CORT is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for CORT: open their intrinsic value pages.